chikungunya virus

Chikungunya is a mosquito-borne human infection caused by the Chikungunya virus (CHIKV) transmitted by mainly two mosquito species: Aedes aegypti, Aedes albopictus, commonly known as Chikungunya mosquito. The Chikungunya virus is a typical RNA virus belonging to the alphavirus genus of the family Togaviridae. The prevalence of this vector-borne infectious disease is mainly observed in tropical and subtropical countries. Due to globalization and increased tourism to the Chikungunya endemic regions, disease outbreaks are reported in Europe and America. Lack of efficient licensed vaccination and definitive chemotherapy for Chikungunya warrants public health authorities of every country at risk to enact strict mosquito control measures to prevent further disease outbreaks. Explore advanced search options by clicking CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS.

Show rows
|< < of > >|

Clinical Presentation of Chikungunya:

Chikungunya is characterized by the sudden onset of high-grade fever accompanied by debilitating arthralgia and joint swelling. The patient also experiences severe headaches, myalgia, nausea, fatigue, and skin rashes resulting in severe disability but rarely causing death. Often the infected individuals become immune against future infections with the Chikungunya virus.

Clinical Diagnosis of  Chikungunya:

Similar to the Clinical presentations of Dengue and Zika virus infection, Chikungunya often confuses physicians to distinguish between viral infections, which eventually leads to misdiagnosis of the illness. Therefore, differential diagnosis of Chikungunya comprises serological testing such as enzyme-linked immunosorbent assays (ELISA) that detect IgM and IgG anti-Chikungunya antibodies.

Besides, virological testing with reverse transcriptase-polymerase chain reaction (RT-PCR) yields virus confirmation with genotyping and allows clear comparisons of virus samples from various geographical sources.

Insight to the Chikungunya Biospecimens We Offer:

Central BioHub offers assiduously tested human biospecimens of Chikungunya ideal for the life science discovery process. Driven by world-class science, Central BioHub connects the worldwide network of certified biosample suppliers to global researchers and scientists with the most straightforward virtual platform. Our online marketplace brings you a broad spectrum of Chikungunya samples subjected to differential diagnostic tests of Chikungunya. Moreover, our samples are hyper-annotated with relevant clinical data and the country or region of sample origin to fuel innovative research.

Central BioHub introduces you to the meticulous collection of human biofluids such as whole blood, saliva, urine, plasma, and serum samples ethically derived from voluntary donors of every age, gender, and ethnicity. Every biofluid derived from the individuals suspected or confirmed with Chikungunya disease is incisively tested for anti-Chikungunya antibodies like Chikungunya IgG (CHIKG), Chikungunya IgM (CHIKM). Ensuring strict compliance to the standards of the Centers for Disease Control and Prevention (CDC), declaration of Helsinki and Taipei, the Chikungunya serum samples are maintained in perfect conditions as small or medium volume samples stored at <-18 °Celsius and <-80 °Celsius (Urine) at our biobank.
With the extreme reputation and global acceptance, we leverage our unparalleled knowledge of online marketing of high-quality, reliable, and cost-effective biospecimens. Our experts at Central BioHub provide every assistance towards easy procurement of interested biospecimens. Prioritizing customer satisfaction, Central BioHub dedicates secure, reliable, and fast worldwide delivery of human biospecimens.